Apogee Therapeutics Inc (APGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 44,122 | 38,181 | 37,155 | 24,305 | 18,885 |
| Operating Income | -44,122 | -38,181 | -37,155 | -24,305 | -18,885 |
| Other Income | 10,306 | 6,087 | 5,420 | 3,465 | 0 |
| Pre-tax Income | -33,816 | -32,094 | -31,735 | -20,840 | -18,885 |
| Net Income Continuous | -33,816 | -32,094 | -31,735 | -20,840 | -18,885 |
| Net Income | $-33,816 | $-32,094 | $-31,735 | $-20,840 | $-18,885 |
| EPS Basic Total Ops | -0.60 | -0.64 | 3.44 | -0.51 | -3.78 |
| EPS Basic Continuous Ops | -0.60 | -0.64 | 3.43 | -0.51 | -3.78 |
| EPS Diluted Total Ops | -0.60 | -0.64 | 3.44 | -0.51 | -3.78 |
| EPS Diluted Continuous Ops | -0.60 | -0.64 | 3.43 | -0.51 | -3.78 |
| EPS Diluted Before Non-Recurring Items | -0.60 | -0.64 | -0.32 | N/A | N/A |
| EBITDA(a) | $-47,126 | $-40,862 | $-39,994 | $-24,305 | $-18,885 |